Literature DB >> 11245423

Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism.

S Ye1, S Dhillon, S J Turner, A C Bateman, J M Theaker, R M Pickering, I Day, W M Howell.   

Abstract

The matrix metalloproteinases (MMPs) are implicated in connective tissue destruction during cancer invasion and metastasis. A naturally occurring variant arising from the insertion or deletion of a guanine in the promoter of the MMP-1 gene has recently been reported and shown to influence its transcriptional activity in melanoma cells. In this study, MMP-1 genotype was determined in 139 Caucasian patients with cutaneous malignant melanoma. The insertion allele was associated with deep invasive, and therefore poorer-prognosis, primary tumors [(34% of patients with vertical growth phase tumor were homozygous for the insertion allele compared with 17% of patients with horizontal growth phase tumor (P = 0.0333; odds ratio = 2.51)]. These data suggest that the invasiveness of cutaneous malignant melanoma is influenced by variation in the MMP-1 gene promoter that affects MMP-1 expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11245423

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  The polymorphism MMP1 -1607 (1G>2G) is associated with a significantly increased risk of cancers from a meta-analysis.

Authors:  Lili Lu; Yujiao Sun; Yiqun Li; Ping Wan
Journal:  Tumour Biol       Date:  2014-11-13

2.  No association of the matrix metalloproteinase 1 promoter polymorphism with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in northern China.

Authors:  Xia Jin; Gang Kuang; Li-Zhen Wei; Yan Li; Rui Wang; Wei Guo; Na Wang; Shu-Mei Fang; Deng-Gui Wen; Zhi-Feng Chen; Jian-Hui Zhang
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

3.  Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression.

Authors:  Hongliang Liu; Qingyi Wei; Jeffrey E Gershenwald; Victor G Prieto; Jeffrey E Lee; Madeleine Duvic; Elizabeth A Grimm; Li-E Wang
Journal:  Melanoma Res       Date:  2012-04       Impact factor: 3.599

4.  Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanoma.

Authors:  Li-E Wang; Yu-jing Huang; Ming Yin; Jeffrey E Gershenwald; Victor G Prieto; Jeffrey E Lee; Madeleine Duvic; Elizabeth A Grimm; Qingyi Wei
Journal:  Eur J Cancer       Date:  2010-07-23       Impact factor: 9.162

5.  Association between matrix metalloproteinase 1 -1607 1G>2G polymorphism and cancer risk: a meta-analysis including 19706 subjects.

Authors:  Guoda Han; Zhijiang Wei; Zhiliang Lu; Haibin Cui; Xiyong Bai; Huai'e Ge; Wei Zhang
Journal:  Int J Clin Exp Med       Date:  2014-09-15

6.  Influence of hepatic arterial blockage on blood perfusion and VEGF, MMP-1 expression of implanted liver cancer in rats.

Authors:  Wei-Jian Guo; Jie Li; Wan-Long Ling; Yong-Rui Bai; Wen-Zhu Zhang; Yu-Fan Cheng; Wen-Hua Gu; Jun-Yan Zhuang
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

7.  Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes.

Authors:  M J Bissell; P A Kenny; D C Radisky
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2005

8.  Polymorphisms of matrix metalloproteinase-7 and chymase are associated with susceptibility to and progression of gastric cancer in Japan.

Authors:  Mitsushige Sugimoto; Takahisa Furuta; Chise Kodaira; Masafumi Nishino; Mihoko Yamade; Mutsuhiro Ikuma; Haruhiko Sugimura; Akira Hishida
Journal:  J Gastroenterol       Date:  2008-10-29       Impact factor: 7.527

9.  Site controlled transgenic mice validating increased expression from human matrix metalloproteinase (MMP-1) promoter due to a naturally occurring SNP.

Authors:  Charles I Coon; Steven Fiering; Justin Gaudet; Colby A Wyatt; Constance E Brinckerhoff
Journal:  Matrix Biol       Date:  2009-07-03       Impact factor: 11.583

Review 10.  Germline determinants of clinical outcome of cutaneous melanoma.

Authors:  Matjaz Vogelsang; Melissa Wilson; Tomas Kirchhoff
Journal:  Pigment Cell Melanoma Res       Date:  2015-11-03       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.